The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the
etiology and risk factors, histologic classification and subtypes, malignant progression risks …

Endometrial Cancer Endometrial carcinoma is diagnosed in about 58,500 women in the
United States per year. It is linked with obesity, excess estrogen, and the Lynch syndrome …

The remit of this guideline is to collate and propose evidence-based guidelines for the
diagnosis and management of uterine cancer. This document covers all uterine cancers of …

Background. Endometrial cancer (EC) is one of the most common gynecologic malignancy,
mostly in postmenopausal women. The gold standard treatment for EC is surgery, but in the …

Simple Summary In this paper we addressed the challenges encountered by women
diagnosed with endometrial cancers during their reproductive years. Depending on the …

Simple Summary There are currently no blood biomarkers approved for routine clinical use
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …

Abstract Purpose Intrauterine levonorgestrel (LNG-IUD) is used to treat patients with
endometrial adenocarcinoma (EAC) and endometrial hyperplasia with atypia (EHA) but …

Simple Summary Wnt has diverse regulatory roles at multiple cellular levels and numerous
targeting points, and aberrant Wnt signaling has crucial roles in carcinogenesis, metastasis …

Simple Summary The incidence and prevalence of endometrial cancer is increasing
globally. The main factors involved in this increase have been the way women live today …

Advanced and recurrent gynecological cancers lack effective treatment and have poor
prognosis. Besides, there is urgent need for conservative treatment for fertility protection of …